CGEM
USDCullinan Therapeutics Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$7.800
Máximo
$7.800
Mínimo
$7.360
Volume
0.61M
Fundamentos da empresa
Capitalização de mercado
437.2M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.89M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ~30% CRc rate observed at clinically
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
CLN-978 led to rapid and deep B cell depletion in vitro and in vivo in multiple autoimmune diseases CAMBRIDGE, Mass., Oct. 25, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (NASDAQ:CGEM), a clinical-stage
Ações relacionadas
QNST
QuinStreet Inc.
HYMCW
Hycroft Mining Holding Corporation Warrant
ENO
Entergy New Orleans LLC First Mortgage Bonds 5.50% Series due April 1 2066
ECPG
Encore Capital Group Inc
ISRG
Intuitive Surgical
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.